Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2025-12-30 @ 2:20 AM
Study NCT ID:
NCT04604132
Status:
TERMINATED
Last Update Posted:
2024-04-04
First Post:
2020-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
Sponsor:
Basilea Pharmaceutica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-21
First Submit QC Date:
None
Study First Post Date:
2020-10-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-11-21
Results First Submit QC Date:
None
Results First Post Date:
2024-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-06
Last Update Post Date:
2024-04-04
Last Update Post Date Type:
ACTUAL